Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ringworm on the skin like athlete's foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Drugs for Dermatophytosis market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Drugs for Dermatophytosis market. Detailed analysis of key players, along with key growth strategies adopted by Drugs for Dermatophytosis industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GSK
Astellas Pharma
Abbott
Pfizer
Enzon Pharmaceuticals
Merck
Sanofi-Aventis
Novartis
Bayer
By Type:
Rx Drug
OTC
By End-User:
Hospitals
Clinics
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Drugs for Dermatophytosis Market
-
1.3 Market Segment by Type
-
1.3.1 China Drugs for Dermatophytosis Market Size and Growth Rate of Rx Drug from 2016 to 2027
-
1.3.2 China Drugs for Dermatophytosis Market Size and Growth Rate of OTC from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Drugs for Dermatophytosis Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Drugs for Dermatophytosis Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 China Drugs for Dermatophytosis Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Drugs for Dermatophytosis Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Drugs for Dermatophytosis by Major Types
-
3.4.1 Market Size and Growth Rate of Rx Drug
-
3.4.2 Market Size and Growth Rate of OTC
4 Segmentation of Drugs for Dermatophytosis Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Drugs for Dermatophytosis by Major End-Users
-
4.4.1 Market Size and Growth Rate of Drugs for Dermatophytosis in Hospitals
-
4.4.2 Market Size and Growth Rate of Drugs for Dermatophytosis in Clinics
-
4.4.3 Market Size and Growth Rate of Drugs for Dermatophytosis in Other
5 Market Analysis by Regions
-
5.1 China Drugs for Dermatophytosis Production Analysis by Regions
-
5.2 China Drugs for Dermatophytosis Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Drugs for Dermatophytosis Landscape Analysis
-
6.1 North China Drugs for Dermatophytosis Landscape Analysis by Major Types
-
6.2 North China Drugs for Dermatophytosis Landscape Analysis by Major End-Users
7 Central China Drugs for Dermatophytosis Landscape Analysis
-
7.1 Central China Drugs for Dermatophytosis Landscape Analysis by Major Types
-
7.2 Central China Drugs for Dermatophytosis Landscape Analysis by Major End-Users
8 South China Drugs for Dermatophytosis Landscape Analysis
-
8.1 South China Drugs for Dermatophytosis Landscape Analysis by Major Types
-
8.2 South China Drugs for Dermatophytosis Landscape Analysis by Major End-Users
9 East China Drugs for Dermatophytosis Landscape Analysis
-
9.1 East China Drugs for Dermatophytosis Landscape Analysis by Major Types
-
9.2 East China Drugs for Dermatophytosis Landscape Analysis by Major End-Users
10 Northeast China Drugs for Dermatophytosis Landscape Analysis
-
10.1 Northeast China Drugs for Dermatophytosis Landscape Analysis by Major Types
-
10.2 Northeast China Drugs for Dermatophytosis Landscape Analysis by Major End-Users
11 Southwest China Drugs for Dermatophytosis Landscape Analysis
-
11.1 Southwest China Drugs for Dermatophytosis Landscape Analysis by Major Types
-
11.2 Southwest China Drugs for Dermatophytosis Landscape Analysis by Major End-Users
12 Northwest China Drugs for Dermatophytosis Landscape Analysis
-
12.1 Northwest China Drugs for Dermatophytosis Landscape Analysis by Major Types
-
12.2 Northwest China Drugs for Dermatophytosis Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 GSK
-
13.1.1 GSK Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Astellas Pharma
-
13.2.1 Astellas Pharma Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Abbott
-
13.3.1 Abbott Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Pfizer
-
13.4.1 Pfizer Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Enzon Pharmaceuticals
-
13.5.1 Enzon Pharmaceuticals Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Merck
-
13.6.1 Merck Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Sanofi-Aventis
-
13.7.1 Sanofi-Aventis Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Novartis
-
13.8.1 Novartis Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Bayer
-
13.9.1 Bayer Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Drugs for Dermatophytosis Market Size and Growth Rate of Rx Drug from 2016 to 2027
-
Figure China Drugs for Dermatophytosis Market Size and Growth Rate of OTC from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Drugs for Dermatophytosis Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Drugs for Dermatophytosis Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure China Drugs for Dermatophytosis Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Drugs for Dermatophytosis Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Drugs for Dermatophytosis Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Drugs for Dermatophytosis
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Drugs for Dermatophytosis by Different Types from 2016 to 2027
-
Table Consumption Share of Drugs for Dermatophytosis by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Rx Drug
-
Figure Market Size and Growth Rate of OTC
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Drugs for Dermatophytosis by Different End-Users from 2016 to 2027
-
Table Consumption Share of Drugs for Dermatophytosis by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Other
-
Table China Drugs for Dermatophytosis Production by Regions
-
Table China Drugs for Dermatophytosis Production Share by Regions
-
Figure China Drugs for Dermatophytosis Production Share by Regions in 2016
-
Figure China Drugs for Dermatophytosis Production Share by Regions in 2021
-
Figure China Drugs for Dermatophytosis Production Share by Regions in 2027
-
Table China Drugs for Dermatophytosis Consumption by Regions
-
Table China Drugs for Dermatophytosis Consumption Share by Regions
-
Figure China Drugs for Dermatophytosis Consumption Share by Regions in 2016
-
Figure China Drugs for Dermatophytosis Consumption Share by Regions in 2021
-
Figure China Drugs for Dermatophytosis Consumption Share by Regions in 2027
-
Table North China Drugs for Dermatophytosis Consumption by Types from 2016 to 2027
-
Table North China Drugs for Dermatophytosis Consumption Share by Types from 2016 to 2027
-
Figure North China Drugs for Dermatophytosis Consumption Share by Types in 2016
-
Figure North China Drugs for Dermatophytosis Consumption Share by Types in 2021
-
Figure North China Drugs for Dermatophytosis Consumption Share by Types in 2027
-
Table North China Drugs for Dermatophytosis Consumption by End-Users from 2016 to 2027
-
Table North China Drugs for Dermatophytosis Consumption Share by End-Users from 2016 to 2027
-
Figure North China Drugs for Dermatophytosis Consumption Share by End-Users in 2016
-
Figure North China Drugs for Dermatophytosis Consumption Share by End-Users in 2021
-
Figure North China Drugs for Dermatophytosis Consumption Share by End-Users in 2027
-
Table Central China Drugs for Dermatophytosis Consumption by Types from 2016 to 2027
-
Table Central China Drugs for Dermatophytosis Consumption Share by Types from 2016 to 2027
-
Figure Central China Drugs for Dermatophytosis Consumption Share by Types in 2016
-
Figure Central China Drugs for Dermatophytosis Consumption Share by Types in 2021
-
Figure Central China Drugs for Dermatophytosis Consumption Share by Types in 2027
-
Table Central China Drugs for Dermatophytosis Consumption by End-Users from 2016 to 2027
-
Table Central China Drugs for Dermatophytosis Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Drugs for Dermatophytosis Consumption Share by End-Users in 2016
-
Figure Central China Drugs for Dermatophytosis Consumption Share by End-Users in 2021
-
Figure Central China Drugs for Dermatophytosis Consumption Share by End-Users in 2027
-
Table South China Drugs for Dermatophytosis Consumption by Types from 2016 to 2027
-
Table South China Drugs for Dermatophytosis Consumption Share by Types from 2016 to 2027
-
Figure South China Drugs for Dermatophytosis Consumption Share by Types in 2016
-
Figure South China Drugs for Dermatophytosis Consumption Share by Types in 2021
-
Figure South China Drugs for Dermatophytosis Consumption Share by Types in 2027
-
Table South China Drugs for Dermatophytosis Consumption by End-Users from 2016 to 2027
-
Table South China Drugs for Dermatophytosis Consumption Share by End-Users from 2016 to 2027
-
Figure South China Drugs for Dermatophytosis Consumption Share by End-Users in 2016
-
Figure South China Drugs for Dermatophytosis Consumption Share by End-Users in 2021
-
Figure South China Drugs for Dermatophytosis Consumption Share by End-Users in 2027
-
Table East China Drugs for Dermatophytosis Consumption by Types from 2016 to 2027
-
Table East China Drugs for Dermatophytosis Consumption Share by Types from 2016 to 2027
-
Figure East China Drugs for Dermatophytosis Consumption Share by Types in 2016
-
Figure East China Drugs for Dermatophytosis Consumption Share by Types in 2021
-
Figure East China Drugs for Dermatophytosis Consumption Share by Types in 2027
-
Table East China Drugs for Dermatophytosis Consumption by End-Users from 2016 to 2027
-
Table East China Drugs for Dermatophytosis Consumption Share by End-Users from 2016 to 2027
-
Figure East China Drugs for Dermatophytosis Consumption Share by End-Users in 2016
-
Figure East China Drugs for Dermatophytosis Consumption Share by End-Users in 2021
-
Figure East China Drugs for Dermatophytosis Consumption Share by End-Users in 2027
-
Table Northeast China Drugs for Dermatophytosis Consumption by Types from 2016 to 2027
-
Table Northeast China Drugs for Dermatophytosis Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Drugs for Dermatophytosis Consumption Share by Types in 2016
-
Figure Northeast China Drugs for Dermatophytosis Consumption Share by Types in 2021
-
Figure Northeast China Drugs for Dermatophytosis Consumption Share by Types in 2027
-
Table Northeast China Drugs for Dermatophytosis Consumption by End-Users from 2016 to 2027
-
Table Northeast China Drugs for Dermatophytosis Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Drugs for Dermatophytosis Consumption Share by End-Users in 2016
-
Figure Northeast China Drugs for Dermatophytosis Consumption Share by End-Users in 2021
-
Figure Northeast China Drugs for Dermatophytosis Consumption Share by End-Users in 2027
-
Table Southwest China Drugs for Dermatophytosis Consumption by Types from 2016 to 2027
-
Table Southwest China Drugs for Dermatophytosis Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Drugs for Dermatophytosis Consumption Share by Types in 2016
-
Figure Southwest China Drugs for Dermatophytosis Consumption Share by Types in 2021
-
Figure Southwest China Drugs for Dermatophytosis Consumption Share by Types in 2027
-
Table Southwest China Drugs for Dermatophytosis Consumption by End-Users from 2016 to 2027
-
Table Southwest China Drugs for Dermatophytosis Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Drugs for Dermatophytosis Consumption Share by End-Users in 2016
-
Figure Southwest China Drugs for Dermatophytosis Consumption Share by End-Users in 2021
-
Figure Southwest China Drugs for Dermatophytosis Consumption Share by End-Users in 2027
-
Table Northwest China Drugs for Dermatophytosis Consumption by Types from 2016 to 2027
-
Table Northwest China Drugs for Dermatophytosis Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Drugs for Dermatophytosis Consumption Share by Types in 2016
-
Figure Northwest China Drugs for Dermatophytosis Consumption Share by Types in 2021
-
Figure Northwest China Drugs for Dermatophytosis Consumption Share by Types in 2027
-
Table Northwest China Drugs for Dermatophytosis Consumption by End-Users from 2016 to 2027
-
Table Northwest China Drugs for Dermatophytosis Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Drugs for Dermatophytosis Consumption Share by End-Users in 2016
-
Figure Northwest China Drugs for Dermatophytosis Consumption Share by End-Users in 2021
-
Figure Northwest China Drugs for Dermatophytosis Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Enzon Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enzon Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Enzon Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Enzon Pharmaceuticals
-
Table Product and Service Introduction of Enzon Pharmaceuticals
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Sanofi-Aventis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis
-
Figure Sales and Growth Rate Analysis of Sanofi-Aventis
-
Figure Revenue and Market Share Analysis of Sanofi-Aventis
-
Table Product and Service Introduction of Sanofi-Aventis
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
